Citigroup’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-582
| Closed | – | – | 5333 |
|
2018
Q4 | $0 | Hold |
582
| – | – | ﹤0.01% | 5284 |
|
2018
Q3 | $1K | Sell |
582
-50
| -8% | -$86 | ﹤0.01% | 5013 |
|
2018
Q2 | $1K | Sell |
632
-3,792
| -86% | -$6K | ﹤0.01% | 4951 |
|
2018
Q1 | $7K | Buy |
4,424
+846
| +24% | +$1.34K | ﹤0.01% | 4572 |
|
2017
Q4 | $8K | Buy |
3,578
+2,907
| +433% | +$6.5K | ﹤0.01% | 4583 |
|
2017
Q3 | $2K | Sell |
671
-89
| -12% | -$265 | ﹤0.01% | 4556 |
|
2017
Q2 | $3K | Sell |
760
-50
| -6% | -$197 | ﹤0.01% | 4511 |
|
2017
Q1 | $3K | Sell |
810
-22,599
| -97% | -$83.7K | ﹤0.01% | 4625 |
|
2016
Q4 | $108K | Buy |
23,409
+20,966
| +858% | +$96.7K | ﹤0.01% | 3878 |
|
2016
Q3 | $10K | Sell |
2,443
-425
| -15% | -$1.74K | ﹤0.01% | 4469 |
|
2016
Q2 | $6K | Sell |
2,868
-7,501
| -72% | -$15.7K | ﹤0.01% | 4684 |
|
2016
Q1 | $48K | Buy |
10,369
+5,527
| +114% | +$25.6K | ﹤0.01% | 4298 |
|
2015
Q4 | $19K | Buy |
4,842
+3,158
| +188% | +$12.4K | ﹤0.01% | 4543 |
|
2015
Q3 | $7K | Sell |
1,684
-23,302
| -93% | -$96.9K | ﹤0.01% | 4549 |
|
2015
Q2 | $114K | Buy |
24,986
+24,160
| +2,925% | +$110K | ﹤0.01% | 3159 |
|
2015
Q1 | $6K | Buy |
826
+74
| +10% | +$538 | ﹤0.01% | 4987 |
|
2014
Q4 | $2K | Buy |
+752
| New | +$2K | ﹤0.01% | 5283 |
|